Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

68.9K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
68.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

548
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
548

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COP9 signalosome 8 mediated autophagy drives proliferation, invasion, and metastasis in pancreatic ductal adenocarcinoma.

Biochemical and biophysical research communications·2026
Same author

Ionic Liquids Functionalized PEDOT:PSS Channel: An Ideal Strategy for Both Accumulation and Depletion Mode OPECT Devices.

Analytical chemistry·2026
Same author

Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of Pain.

ACS medicinal chemistry letters·2026
Same author

Physiological super-resolution in situ recording reveals kinetic changes of sympathetic norepinephrine release in heart failure.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Interface engineering of fcc-RuCo@hcp-Ru core-shell nanoplates for efficient industrial alkaline hydrogen evolution.

Chemical communications (Cambridge, England)·2026
Same author

Association of VitD 3 deficiency with thyroid nodules suspected of malignancy in petroleum workers: a retrospective cohort study.

PeerJ·2026

Related Experiment Video

Updated: Oct 30, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.3K

Flavivirus: From Structure to Therapeutics Development.

Rong Zhao1,2, Meiyue Wang1,2, Jing Cao1,2

  • 1Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China.

Life (Basel, Switzerland)
|July 2, 2021
PubMed
Summary

Flaviviruses pose a significant global health risk, with limited effective treatments. This review explores strategies for developing new vaccines and antiviral drugs targeting flavivirus proteins.

Keywords:
drug targetepidemicsflavivirusimmunologyprotein structurevaccine

More Related Videos

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

13.4K
Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

21.6K

Related Experiment Videos

Last Updated: Oct 30, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.3K
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

13.4K
Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

21.6K

Area of Science:

  • Virology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Flaviviruses, including Dengue and Zika viruses, represent a growing global health concern.
  • Current therapeutic drugs and vaccines for flavivirus infections are underdeveloped.
  • The Flaviviridae family includes enveloped viruses with single-strand RNA genomes encoding ten essential proteins.

Purpose of the Study:

  • To review key information on flaviviruses.
  • To introduce strategies for designing vaccines and antiviral drugs based on viral protein structures.
  • To highlight progress and remaining challenges in flavivirus therapeutic development.

Main Methods:

  • Literature review of flavivirus biology and protein structures.
  • Analysis of current antiviral drug and vaccine development strategies.
  • Synthesis of information on flavivirus infection mechanisms.

Main Results:

  • Understanding flavivirus biology has advanced antiviral drug studies.
  • No universally effective antiviral drugs or vaccines currently exist for most flaviviruses.
  • Viral protein structures offer promising targets for drug and vaccine design.

Conclusions:

  • Further research into flavivirus protein structures is crucial for developing effective countermeasures.
  • Targeted drug design based on viral proteins shows potential for new therapies.
  • Continued development of vaccines and antiviral compounds is urgently needed to combat flavivirus threats.